Spontaneous reports of suspected adverse reactions are an important source of information for pharmacovigilance activities, as they allow the detection of potential warning signals related to the use of all drugs available on the national territory. Pharmacovigilance involves the entire community at different levels: patients, prescribers, healthcare professionals, pharmaceutical companies, institutions and academia.
Reporting of suspected adverse reactions can be done not only by healthcare professionals but also by citizens, using specific forms available on the Ministry of Health website.

Slais Srl provides the following email address, relating to all issues related to adverse drug reports: farmacovigilanza@slais.it